D
Translational Development Acquisition Corp. TDAC
$10.45 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 915.60K 763.20K 543.80K 197.20K 547.60K
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 915.60K 763.20K 543.80K 197.20K 547.60K
Operating Income -915.60K -763.20K -543.80K -197.20K -547.60K
Income Before Tax 4.76M 3.04M 1.41M -71.80K -547.60K
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 4.76 3.04 1.41 -0.07 -0.55
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 4.76M 3.04M 1.41M -71.80K -547.60K
EBIT -915.60K -763.20K -543.80K -197.20K -547.60K
EBITDA -- -- -- -- --
EPS Basic 0.22 0.13 0.05 -0.02 -0.14
Normalized Basic EPS 0.14 0.08 0.03 -0.01 -0.08
EPS Diluted 0.22 0.13 0.05 -0.02 -0.14
Normalized Diluted EPS 0.14 0.08 0.03 -0.01 -0.08
Average Basic Shares Outstanding 71.14M 53.28M 35.43M 17.57M 16.20M
Average Diluted Shares Outstanding 71.14M 53.28M 35.43M 17.57M 16.20M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --